DURHAM – Clinetic, a life science startup focusing on patient recruitment for clinical trials and related data, says it has closed its Series A funding round with the backing of Sopris Capital.
The amount of the funding was not disclosed.
In 2021, Clinetic disclosed raising $6.4 million from four investors.
The Duke spinout explains that its platform embeds research data curation capabilities into standard care delivery workflows. It can be deployed for specific trials but is highly adaptive to be used for other trials or quality improvement and efficiency applications.
“We are thrilled to partner with an investor who shares our vision for modernizing clinical research,” said Tom Kaminski, co-founder and chief executive officer of Clinetic, in the announcement. “Our data-driven software platform streamlines highly manual activities for both health systems and life science companies to ultimately complete studies faster and advance new therapies to improve patient care.”
The company says the funding will be used “to accelerate its patient recruitment and real-world data capabilities” and other business-building strategies. Its recruitment technology is based on electronic health record data and patient relationships.
More Clinetic news
Health data startup Clinetic adds to growing list of clinical trial partners
“The platform also enables researchers to surface deep, timely clinical insights for real-world data studies,” Clinetic says.
“As active investors in technology-enabled healthcare services and SaaS companies, we recognize the compelling and differentiated value proposition of Clinetic,” said Mark Groner, Partner at Sopris Capital. “Their unique platform to surface deep clinical data insights and streamline the ‘last mile’ of patient recruitment represents a promising solution to a critical unfilled need in clinical research and healthcare. We are excited about its trajectory and future growth.”
